Goldman Sachs sees up to 28% upside in two ‘consensus buy’ pharma stocks

Goldman Sachs believes Piramal Pharma is well-placed within its coverage to deliver top-quartile profit growth driven by very high operating financial leverage.

Goldman Sachs believes Piramal Pharma is well-placed within its coverage to deliver top-quartile profit growth driven by very high operating financial leverage.

As per the latest exchange data, PAG holds 54.93% stake in Nuvama Wealth Management. Based on the market cap of the target firm at the end of day’s trade on April 7, the PAG stake was worth ₹10,579 crore.

Post Content

Average price realisation for Sobha was higher, both for the quarter as well as for the full year, the company highlighted in its exchange filing.

Analysts say Apple will likely either need to raise prices or eat additional tariff costs when the new duties come into effect. UBS analysts estimated on Monday that Apple’s highest-end iPhone could rise in price by about $350, or around…

Sensex Today | Stock Market LIVE Updates: Indian benchmark indices Nifty 50 and Sensex witnessed an extremely volatile session on Monday, ending around 3% lower, each, post the Trump tariffs-led US market and global markets crash. Nifty 50 closed at…

Shares in Japan and Australia advanced along with equity-index futures for the S&P 500 and the Nasdaq 100, both gaining more than 1%. Contracts for Hong Kong pointed to losses after a gauge of US-listed Chinese shares fell more than…

Brent rose toward $65 a barrel after hitting a four-year low in the previous session, while West Texas Intermediate traded above $61.

India’s equity benchmarks fell sharply on Monday but recovered from the lows of the session, recovering nearly 40% of the total fall towards the close of trade.

Hedge funds increased short positions across a range of US macro products by 22% last week, marking the largest jump in more than a decade, wrote Vincent Lin at Goldman Sachs Group Inc.